Immunohistochemical detection of proliferating cell nuclear antigen in middle ear cholesteatoma.
Cholesteatoma epithelium is characterized by a keratinocyte dysregulation accompanied by destruction of the ossicles and temporal bone. Immunohistochemical methods using antibodies to cell-cycle-related antigens can be used as a means for assessing various aspects of proliferation in cholesteatoma tissue. They also have the important advantage of preserving the spatial orientation of proliferating cells in histological sections. Proliferating cell nuclear antigen (PCNA) is a 36 kDa DNA-delta-polymerase-associated protein that is directly involved in the mechanisms of DNA synthesis. In the present study the expression of PCNA was investigated in formalin-fixed, paraffin-embedded biopsy specimens of cholesteatomas and normal skin. Normal skin revealed nuclear staining in a small number of keratinocytes (PCNA grade, 1.5) located in the basal cell layer. In contrast, an increased number of PCNA-labeled basal and suprabasal epidermal cells (PCNA grade, 9.3) were found in cholesteatoma samples. Our findings indicate that PCNA represents a reliable marker for epithelial proliferation, showing that cholesteatoma epithelium proliferates at a higher rate than normal epidermis. These findings also support the concept of keratinocyte dysregulation in middle ear cholesteatoma.
Bujia
J
J
Department of Otorhinolaryngology, Ludwid-Maximilians-University, Klinikum Grobhadern, Munich, Germany.
Sudhoff
H
H
Holly
A
A
Hildmann
H
H
Kastenbauer
E
E
D002455:Cell Division / Q000502:physiology; D002467:Cell Nucleus / Q000473:pathology; D018424:Cholesteatoma, Middle Ear / Q000473:pathology*; D004261:DNA Replication / Q000502:physiology; D004432:Ear, Middle / Q000473:pathology; D004848:Epithelium / Q000473:pathology; D006801:Humans; D007124:Immunoenzyme Techniques; D015603:Keratinocytes / Q000473:pathology; D018809:Proliferating Cell Nuclear Antigen / Q000032:analysis*; D012867:Skin / Q000473:pathology
D018809:Proliferating Cell Nuclear Antigen